Human cell-based model of thoracic aortic aneurysm offers new opportunities for drug development

FHS
May 14, 2024
8:23 pm

Using human cells in laboratory rats, Michigan Medicine researchers have developed a functional model of thoracic aortic aneurysm, creating opportunities for more effective understanding of disease development and treatments for the potentially fatal condition, a study suggests.

Takeda extends rare disease awareness campaign with patient-inspired imagery, stories

Takeda is continuing to highlight the unpredictable burden of hereditary angioedema in its “Discover HAE” campaign, incorporating more personal stories and imagery that reflect patient

April 9, 2024

Digital tech could unlock warning signs for imminent sudden cardiac arrest

A new study in Lancet Digital Health identifies early warning symptoms like chest pain and dyspnea that are moderately associated with imminent sudden cardiac arrest.

September 4, 2023

AstraZeneca picks up rare disease-focused Amolyt Pharma in $1 billion deal

LONDON — AstraZeneca said Thursday it would purchase the French firm Amolyt Pharma in a deal worth up to $1 billion, picking up a rare disease

March 14, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.